GGrantIndex
Sort

53,477 grants matching addiction

GENETICS, THE ADOLESCENT BRAIN, AND ADDICTION LIABILITY: A LONGITUDINAL TWIN STUDY

$622,080
Andrey P. Anokhin · Washington University · R01 · FY2017 · HD

Alaska Native Family-Based, Financial Incentives Intervention for Smoking Cessation: an RCT

$622,059
Christi A Patten · Mayo Clinic Rochester · R01 · FY2024 · DA

Smokers’ Decision-Making about Tobacco Use: The Interplay of Affective and Cognitive Factors with Product Characteristics

$622,051
Terry Frank Pechacek · Georgia State University · R01 · FY2020 · CA

Clinical Research Resources and Facilities

$622,019
Judith E Feinberg · West Virginia University · U54 · FY2020 · GM

Enhancing Prospection with Virtual Reality in Alcohol Use Disorder Recovery

$621,998
Brandon G Oberlin · Indiana University Indianapolis · R01 · FY2025 · AA

Randomized-controlled trial of virtual reality for chronic low back pain to improve patient-reported outcomes and physical activity

$621,894
Brennan Spiegel · Cedars-Sinai Medical Center · UH3 · FY2023 · AR

To Test A Payer/Treatment Agency Intervention to Increase Use of Buprenorphine

$621,816
Todd David Molfenter · University Of Wisconsin-Madison · R01 · FY2012 · DA

Alcohol Problems &Service Dynamics after Welfare Reform

$621,791
Public Health Institute · R01 · FY2003 · AA

PRACT: A Pragmatic Randomized Adaptive Clinical Trial to Investigate Controlling Alcohol related harms in a Low-Income Setting; Emergency Department Brief Interventions in Tanzania

$621,772
Catherine Ann Staton · Duke University · R01 · FY2023 · AA

Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children

$621,620
Sharon S Allen · University Of Minnesota · R01 · FY2025 · HD

Research Education Core

$621,603
Danielle Sheldon Rudes · George Mason University · U2C · FY2023 · DA

Small molecule modulators of ΔFosB function

$621,574
Gabrielle Rudenko · University Of Texas Med Br Galveston · R01 · FY2017 · DA

Small molecule modulators of ΔFosB

$621,544
Gabrielle Rudenko · University Of Texas Med Br Galveston · R01 · FY2023 · DA

Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies

$621,510
Vito Quaranta · Vanderbilt University · R01 · FY2014 · CA

Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies

$621,510
Vito Quaranta · Vanderbilt University · R01 · FY2015 · CA

Microfabricated all-diamond microelectrode arrays for neurotransmitter sensing and extracellular recording

$621,455
Wen Li · Michigan State University · R01 · FY2021 · NS

Automated Facial Expression Analysis for Research and Clinical Use

$621,438
Jeffrey F Cohn · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · MH

Finding the projection-specific dopaminergic synaptic organizers

$621,415
Hisashi Umemori · Boston Children'S Hospital · R01 · FY2017 · DA

Randomized ESRD Trial COmparing CBT alone VERsus with buprenorphine (RECOVER)

$621,362
Rajnish Mehrotra · University Of Washington · U01 · FY2022 · DK

Middle School Cluster RCT to Evaluate E-Cigarette Prevention Program: CATCH My Breath

$621,352
Steven H Kelder · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA

Diagnostic and prognostic biomarkers for subtypes of addiction-related circuit dysfunction

$621,348
Conor M Liston · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · DA

Akt/GSK-3 Signaling Cascade and the Actions of Dopamine

$621,286
Marc G. Caron · Duke University · R37 · FY2011 · MH

Interdisciplinary Research Training in Pain and/or Substance Use Disorders

$621,235
Sean C Mackey · Stanford University · T32 · FY2020 · DA

Community-based, client-centered prevention homes to address the rural opioid epidemic

$621,231
Ryan Patrick Westergaard · University Of Wisconsin-Madison · UG3 · FY2017 · DA

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

$621,183
Marek C Chawarski · Yale University · R01 · FY2012 · DA